Analyst picks & changes
In his first report since joining Merrill Lynch, Jeffrey Casdin presented an overview of the biotech sector and initiated coverage on seven companies: Amgen Inc., Biogen Inc.,
Gathering data...
In his first report since joining Merrill Lynch, Jeffrey Casdin presented an overview of the biotech sector and initiated coverage on seven companies: Amgen Inc., Biogen Inc.,